Enhanc3D Genomics appoints Hazel Jones as Chief Executive Officer

FHS
May 15, 2024
9:10 am

Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D genome for use in novel target identification and unique patient stratification, today announced the appointment of Hazel Jones as Chief Executive Officer, after a successful six-month tenure as interim CEO and COO.

Patient records exposed in data breaches doubled in 2023

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The number of patient records

January 23, 2024

Texan activists thirst for a national heat standard to protect outdoor workers

Construction workers, airport baggage handlers, letter carriers, and other outdoor workers — many of whom traveled to Washington, D.C., from Texas — gathered at the

July 28, 2023

Patients See Better Outcomes With Female Surgeons, Studies Find

Patients treated by women surgeons had better outcomes, according to two population-based cohort studies from Canada and Sweden, both of which were published in JAMA

September 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.